Could treating gum disease with a laser also improve blood sugar levels? New research suggests that laser treatment for gum disease may offer benefits beyond oral health for people with type 2 diabetes. A randomized clinical trial involving 120 adults found that adding laser therapy to conventional periodontal treatment improved gum health and produced modest improvements in A1C and fasting glucose. However, the findings raise an important question: Does laser treatment directly improve diabetes, or does reducing gum inflammation simply support better metabolic health?
Table of Contents
- How diabetes and periodontal disease are connected
- What the 120-patient laser therapy trial found
- Understanding the A1C results and study limitations
- Clinical implications for diabetes and dental care
- Conclusion
- Frequently asked questions
How Diabetes and Periodontal Disease Are Connected
Periodontitis is a chronic inflammatory condition that damages the gums and tissues supporting the teeth. It begins when bacterial plaque builds up around and below the gumline. Over time, untreated inflammation can lead to deep periodontal pockets, bone loss, and tooth loss.
For people with type 2 diabetes, this problem can be especially challenging. Elevated blood glucose can impair immune responses and slow healing. Consequently, patients may experience more severe periodontal inflammation and greater difficulty recovering from infections.
The relationship also works in the opposite direction. Chronic gum inflammation may contribute to insulin resistance, potentially making blood glucose harder to manage. As a result, researchers increasingly view periodontal health as part of comprehensive diabetes care.
The American Dental Association's guidance on diabetes and oral health describes this two-way relationship and supports appropriate periodontal care for people with diabetes.
Likewise, Diabetes in Control previously explored this connection in its article Why Oral Health Is Becoming Part of Diabetes Management.
What the 120-Patient Periodontal Laser Treatment Trial Found
Researchers at the Affiliated Hospital of Chengdu University conducted a randomized controlled trial published on November 2, 2026, in the Journal of International Medical Research. The study examined whether adding a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser improved periodontal outcomes beyond standard nonsurgical care.
Investigators randomly assigned 120 adults with type 2 diabetes and periodontitis to two groups. Sixty participants received conventional scaling and root planing, while another 60 received the same treatment plus laser therapy. Both groups also received oral hygiene instructions and follow-up care.
Scaling and root planing removes plaque and hardened deposits from beneath the gums. Meanwhile, adjunctive laser treatment targets diseased tissue inside periodontal pockets. Researchers measured periodontal health and metabolic outcomes over six months.
The primary result favored laser-assisted care. Compared with conventional treatment alone, the laser group had an adjusted mean periodontal pocket depth 0.70 millimeters lower at six months.
Additional findings included:
- Clinical attachment level improved by an adjusted 0.67 millimeters compared with the control group.
- Bleeding-positive periodontal sites were 11.3 percentage points lower.
- A1C was 0.26 percentage points lower after adjustment for baseline levels.
- Fasting plasma glucose was approximately 11 mg/dL lower after adjustment.
All these differences were statistically significant. However, the laser group also showed slightly greater gum recession, with an adjusted difference of 0.09 millimeters.
No serious treatment-related adverse events were reported.
Together, these findings suggest that adjunctive Nd:YAG laser therapy may offer additional short-term periodontal benefits for selected patients with type 2 diabetes.
What the A1C Results Mean and Why Caution Is Needed
The blood sugar findings are particularly interesting, but they require careful interpretation. In the laser group, average A1C decreased from 7.27% to 6.85%. By comparison, the conventional-treatment group experienced a smaller decrease, from 7.37% to 7.21%.
Although these results favor laser-assisted care, A1C was a secondary outcome rather than the trial's primary objective. Therefore, the study was not designed to establish laser therapy as a treatment for diabetes.
Furthermore, the study involved one medical center, had no formal advance sample-size calculation, and followed participants for only six months. Most participants also had advanced periodontal disease and relatively stable diabetes management. The trial was registered retrospectively, adding another methodological limitation.
Previous research on laser-assisted periodontal treatment has also produced mixed results. While some studies suggest short-term improvements in glycemic control, evidence remains insufficient to recommend routine laser treatment specifically for lowering A1C.
Therefore, larger, longer clinical trials are needed to determine whether laser-assisted periodontal therapy provides lasting benefits for blood sugar control in people with diabetes.
Clinical Implications for Diabetes and Dental Care
For healthcare professionals, these findings reinforce the importance of including periodontal health in routine diabetes assessments. Patients reporting bleeding gums, loose teeth, or persistent gum inflammation may benefit from a periodontal evaluation.
However, conventional scaling and root planing remains the foundation of nonsurgical periodontal treatment. Laser therapy should be considered an additional option rather than a replacement.
These findings also highlight the importance of collaboration between dental professionals and diabetes care teams when managing patients with type 2 diabetes and periodontal disease.
Regular dental assessments, effective brushing, interdental cleaning, and appropriate glucose management remain essential. Furthermore, clinicians should explain that better periodontal health may support overall diabetes care without guaranteeing lower A1C levels.
Patients should continue prescribed medications, including metformin, insulin, or GLP-1 receptor agonists when indicated.
For individualized medical guidance, patients can consult their healthcare team or seek professional support through Healthcare.pro.
Conclusion
This randomized trial provides encouraging evidence that laser-assisted periodontal care can improve gum health in adults with type 2 diabetes. The additional A1C and fasting glucose improvements are noteworthy but remain secondary findings.
Ultimately, these findings reinforce the importance of periodontal care in diabetes management. Although laser therapy may provide additional benefits for gum health, it should not replace established treatments for controlling blood glucose.
Frequently Asked Questions
- Can periodontal laser treatment lower A1C?
One randomized trial found a modest A1C improvement compared with conventional dental treatment alone. However, larger studies are needed to confirm this benefit. - Is laser therapy better than traditional gum treatment?
The trial found better short-term periodontal outcomes when laser therapy was added to scaling and root planing. Nevertheless, conventional care remains essential. - Can gum disease make diabetes harder to control?
Yes. Chronic periodontal inflammation may contribute to insulin resistance and make blood glucose management more difficult. - Should everyone with type 2 diabetes receive laser gum treatment?
No. Treatment decisions depend on periodontal disease severity, individual needs, costs, and available clinical evidence. - Can laser gum treatment replace diabetes medication?
No. Laser-assisted periodontal care is a dental treatment, not a substitute for prescribed diabetes medications or ongoing glucose monitoring.
This content is not medical advice. For any health issues, always consult a healthcare professional. In an emergency, call 911 or your local emergency services.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.